2 June 2017 - The Canadian pERC has recommended the funding of obinutuzumab (Gazyva) for use by adults with non-Hodgkin's ...
8 May 2017 - AstraZeneca is committed to rapid and collaborative discussions with pan-Canadian Pharmaceutical Alliance and provinces to get ...
26 April 2017 - Jennifer McGrady has never even touched a cigarette. ...
30 March 2017 - The outcome relates to the use of obinutuzumab in combination with chemotherapy followed by obinutuzumab monotherapy ...
30 March 2017 - The recommendation relates to the use of vandetanib for the treatment of symptomatic and/or progressive medullary ...
30 March 2017 - The outcome relates to the use of carfilzomib in combination with dexamethasone by patients with relapsed ...
28 March 2017 - Roche was seeking a positive CADTH recommendation for the use of bevacizumab in combination with pemetrexed ...
6 March 2017 - Interesting insights from the pCODR Initial Economic Guidance Report for alectinib hydrochloide (Alecensaro). ...
3 March 2016 - The outcome for three medicines, ceritinib (Zykadia), osimertinib mesylate (Tagrisso) and alectinib hydrochloride (Alecensaro), demonstrate the ...
10 January 2017 - Abbvie was seeking funding for venetoclax when used as a treatment for patients with chronic lymphocytic ...
13 December 2016 - A British Colombia woman says a new immuno-oncology drug that saved her life is not available ...
1 December 2016 - The outcome relates to the use of everolimus for the treatment of patients with a neuroendocrine ...
1 December 2016 - The outcome relates to the use of daratumumab for the treatment of patients with multiple myeloma. ...
1 December 2016 - The outcome relates to the use of venetoclax for the treatment of patients with chronic lymphocytic ...
21 November 2016 - CADTH has published a final outcome for palbociclib following a resubmission from Pfizer. ...